ロード中...
Pembrolizumab‐induced sarcoid granulomatous panniculitis and bullous pemphigoid in a single patient
Pembrolizumab is an immune checkpoint inhibitor with antitumor activity in other organ malignancies. We present this case —demonstrating multiple inflammatory adverse events associated with Pembrolizumab (in a single patient), in order to increase awareness and facilitate earlier identification of t...
保存先:
| 出版年: | Clin Case Rep |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6452463/ https://ncbi.nlm.nih.gov/pubmed/30997084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.2090 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|